An interventional study of Islamic-Oriented Ericksonian Hypnotherapy (IEH) and Standard Ericksonian Hypnotherapy (SEH) in Anxiety Disorders and Depressive Disorder, sponsored by Istanbul Nisantasi University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-26.
Sponsored by Istanbul Nisantasi University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 1,266 studies in Anxiety Disorders with a site in Turkey — 236 open to participants now, 277 under way, none of them phase 3. Anxiety Disorders · Turkey.
Among the 1,266 studies in Anxiety Disorders with a site in Turkey, this one is the 383rd largest by planned enrollment of the 1,124 interventional ones that give a count, is one of 244 that started in 2025, is one of 1,118 with no phase, reaches primary completion later than 76 of the 276 other live ones, and was the 757th registered.
7,249 studies on the registry are indexed under Anxiety Disorders; 1,691 are open to participants now.
Browse Anxiety Disorders studies →236 of the 1,266 studies in Anxiety Disorders with a site in Turkey are open now. Recruiting first, the newest first:
Artvin Coruh University · Sites in Turkey
Ages 8–11
Artvin Coruh University · Sites in Turkey
Ages 6–12
Mersin University · Sites in Turkey
Ages 18+
Istanbul Nisantasi University · Sites in Turkey
Ages 18+ · Healthy volunteers
Konya Beyhekim Training and Research Hospital · Sites in Turkey
Ages 40–55 · Women only
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 947 Anxiety Disorders studies recruiting now, 423 (45%) set no upper age limit and 455 (48%) stop at 75 or younger; 233 take children under 18; 319 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
1,266 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 244 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 90 is above the median of 80 across 6,103 interventional studies indexed under Anxiety Disorders.
Median enrollment 78 across the 1,124 interventional studies, 103 across the 142 observational. Of the 932 that completed or were terminated, 2 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 1,266 have an industry lead sponsor. The 10 most frequent:
Istanbul Nisantasi University is the lead sponsor of 22 studies on the registry; 8 are open to participants now.
Istanbul Nisantasi University has 3 studies filed under Anxiety Disorders — fewer than ten, so there is no comparison to draw.
69 of the studies in Anxiety Disorders with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07846410Istanbul Physical Medicine Rehabilitation Training and Research HospitalVirtual Reality-Based Hypnotherapy for Pain, Sleep, and Mood in Spinal Cord Injury | 2026-11 |
| NCT07444697Kırıkkale University"Erectile Function After PCI in MI and Non-MI Patients" | 2026-11 |
| NCT07517549Ordu UniversitySexual Health Education During Pregnancy | 2026-11-30 |
| NCT07936305Serpil UyarVirtual Reality Headset Intervention on Pain, Anxiety, and Vital Signs in Pregnant Women Following Vaccination | 2026-12-01 |
| NCT07833709Sakarya UniversityEffectiveness of a Mindfulness-Based Cognitive Behavioral Mobile Intervention for Misophonia | 2026-12-03 |
Add all 69 to your calendar (.ics) → With an account.
Among the 1,266 studies in Anxiety Disorders with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled trial (RCT) aims to compare the effectiveness of Islamic-Oriented Ericksonian Hypnotherapy (IEH) and Standard Ericksonian Hypnotherapy (SEH) in reducing symptoms of anxiety and depression. The study will enroll 90 participants with mild to moderate anxiety and depression, who will be randomly assigned to one of three groups: (1) IEH intervention, (2) SEH intervention, or (3) control group (no intervention). Participants in the intervention groups will receive 12 weekly hypnotherapy sessions, each lasting 60 minutes. The primary outcomes include changes in Beck Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI) scores from baseline to post-intervention and at a 4-week follow-up.
The study will also assess whether religious belief levels moderate the effects of the intervention using the OK-Religious Attitude Scale. Data collection will be performed at Istanbul Nişantaşı University, and ethical approval has been obtained.
This randomized controlled trial evaluates the differential effects of Islamic-Oriented Ericksonian Hypnotherapy (IEH) and Standard Ericksonian Hypnotherapy (SEH) in alleviating symptoms of anxiety and depression among religious Muslim adults. The primary objective is to examine whether the integration of Islamic religious elements into Ericksonian hypnotherapy enhances clinical outcomes compared to its standard application.
The study follows a parallel-group design with three arms: IEH, SEH, and a no-intervention control. Ninety participants (30 per group) are randomized using stratified block randomization based on age and gender. All intervention sessions are manualized, delivered by trained clinical psychologists, and conducted weekly over 12 weeks (each lasting 60 minutes).
IEH sessions incorporate culturally and religiously adapted therapeutic elements, such as Quranic metaphors, Islamic imagery, and spiritual affirmations, in line with the Ericksonian framework. SEH sessions utilize traditional hypnotic techniques including metaphorical storytelling, guided imagery, and indirect suggestions, without religious content.
Primary outcome measures include changes in Beck Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI) scores from baseline to Week 12 (post-intervention) and Week 16 (follow-up). Secondary analyses will investigate whether religiosity levels (measured via the OK-Religious Attitude Scale) moderate treatment effects. Blinded outcome assessors will ensure unbiased data collection.
This study addresses the need for culturally responsive mental health interventions within Muslim populations. Ethical approval was obtained from the İstanbul Nişantaşı University Ethics Committee (Approval No: 20250103-27). Results are expected to contribute to evidence-based development of spiritually integrated psychotherapeutic models for anxiety and depression.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receive 12 weekly sessions of Islamic-Oriented Ericksonian Hypnotherapy (IEH), which integrates faith-based imagery, Quranic metaphors, and religiously adapted hypnotic suggestions alongside standard Ericksonian techniques. Each session lasts 60 minutes.
Behavioral: Islamic-Oriented Ericksonian Hypnotherapy (IEH)
Participants receive 12 weekly sessions of Standard Ericksonian Hypnotherapy (SEH), using metaphorical storytelling, indirect suggestions, guided imagery, and hypnotic language patterns without religious integration. Each session lasts 60 minutes.
Behavioral: Standard Ericksonian Hypnotherapy (SEH)
Participants do not receive any intervention but will complete assessments at baseline, post-intervention (Week 12), and follow-up (Week 16).
This intervention involves 12 weekly sessions (60 minutes each) of Ericksonian hypnotherapy integrated with Islamic religious elements. Sessions incorporate: Quranic metaphors and Islamic imagery Spiritual affirmations to enhance relaxation and emotional regulation Faith-based guided hypnosis adapted to cultural and religious beliefs Techniques such as indirect suggestions, therapeutic storytelling, and guided imagery The intervention is designed for Muslim participants with mild to moderate anxiety and depression.
Participants receive 12 weekly sessions (60 minutes each) of standard Ericksonian hypnotherapy, which includes: Metaphorical storytelling and guided imagery Indirect hypnotic suggestions to promote psychological flexibility Relaxation techniques to reduce anxiety and depressive symptoms Unlike the Islamic-Oriented Hypnotherapy (IEH), this intervention does not integrate religious or faith-based elements.
Beck Depression Inventory-II (BDI-II)
The study evaluates the effectiveness of Islamic-Oriented Ericksonian Hypnotherapy (IEH) vs. Standard Ericksonian Hypnotherapy (SEH) vs. No Intervention in reducing depressive symptoms. Depression severity will be assessed using the Beck Depression Inventory-II (BDI-II), comparing baseline, post-intervention (Week 12), and follow-up (Week 16) scores.
Time frame: Baseline, Week 12 (post-intervention), Week 16 (follow-up)
Beck Anxiety Inventory (BAI)
The study measures reductions in anxiety symptoms among participants receiving IEH, SEH, or no intervention. Anxiety severity will be assessed using the Beck Anxiety Inventory (BAI), comparing scores from baseline to post-intervention and follow-up.
Time frame: Baseline, Week 12, Week 16
Plan to share: Yes — Deidentified individual participant data (IPD) will be shared upon publication of the study results in a peer-reviewed journal. The shared dataset will include anonymized scores from outcome measures (e.g., BDI-II, BAI) and will exclude any personally identifiable information. Data will be available upon reasonable request for research purposes.
Supporting information: Study protocol, Statistical analysis plan, Clinical study report
Time frame: IPD and supporting information will be available after publication of study results and will remain accessible for five years post-publication.
Access criteria: Researchers requesting access must submit a formal request specifying their intended use of the data. Access will be granted upon institutional review and approval by the research team. Requests can be made by contacting the corresponding author via email.
No publications or documents are linked to this record.
Started Jan 2025 (actual). Primary completion is estimated for Jun 2025, 5 months after the start.
Of 3,871 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 5 months is below that.
Counting every sponsor, half of 3,976 studies reached it within 12 months; a quarter within 5 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istanbul Nisantasi University